Women's role in reproductive health decision making and vulnerability to STD and HIV/AIDS in Ekiti, Nigeria

An exploratory study of women’s role in reproductive decision making in Ekiti shows that women in the state are increasingly taking active decisions on matters affecting their daily lives. More women than ever before believed that they could take decisions on family size, when to have a baby and choice of spacing period. The cultural barrier against short postpartum abstinence appeared to have diminished and sex during lactation was not considered a major cultural and religious taboo. Knowledge of contraception has become universal in recent years, and the majority of women take decisions on the method and timing of family planning. All women who used family planning considered their decision in this regard very important. The ability of women to take decisions on these issues may not only enhance their bargaining power but also reduce their vulnerability to STDs including AIDS from diseased or high-risk partners

Thrombin and factor Xa link the coagulation system with Liver fibrosis

Background: Thrombin activates hepatic stellate cells via protease-activated receptor-1. The role of Factor Xa (FXa) in hepatic fibrosis has not been elucidated. We aimed to evaluate the impact of FXa and thrombin in vitro on stellate cells and their respective inhibition in vivo using a rodent model of hepatic fibrosis. Methods: HSC-LX2 cells were incubated with FXa and/or thrombin in cell culture, stained for αSMA and relative gene expression and gel contraction calculated. C57BL/6 J mice were administered thioacetamide (TAA) for 8 weeks with Rivaroxaban (n = 15) or Dabigatran (n = 15). Control animals received TAA alone (n = 15). Fibrosis was scored and quantified using digital image analysis and hepatic tissue hydroxyproline estimated. Results Stellate cells treated with FXa and thrombin demonstrated upregulation of procollagen, TGF-beta, αSMA and significant cell contraction (43.48%+/− 4.12) compared to culturing with FXa or thrombin alone (26.90%+/− 8.90, p = 0.02; 13.1%+/− 9.84, p < 0.001). Mean fibrosis score, percentage area of fibrosis and hepatic hydroxyproline content (2.46 vs 4.08, p = 0.008; 2.02% vs 3.76%, p = 0.012; 276.0 vs 651.3, p = 0.0001) were significantly reduced in mice treated with the FXa inhibitor compared to control mice. FXa inhibition was significantly more effective than thrombin inhibition in reducing percentage area of fibrosis and hepatic hydroxyproline content (2.02% vs 3.70%,p = 0.031; 276.0 vs 413.1,p = 0.001). Conclusions: FXa promotes stellate cell contractility and activation. Early inhibition of coagulation using a FXa inhibitor significantly reduces TAA induced murine liver fibrosis and may be a viable treatment for liver fibrosis in patients

Tensionless structure of glassy phase

We study a class of homogeneous finite-dimensional Ising models which were recently shown to exhibit glassy properties. Monte Carlo simulations of a particular three-dimensional model in this class show that the glassy phase obtained under slow cooling is dominated by large scale excitations whose energy $E_l$ scales with their size $l$ as $E_l\sim l^{\Theta}$ with $\Theta\sim 1.33(5)$. Simulations suggest that in another model of this class, namely the four-spin model, energy is concentrated mainly in linear defects making also in this case domain walls tensionless. Two-dimensinal variants of these models are trivial and energy of excitations scales with the exponent $\Theta=1.05(5)$.Comment: 5 page

A Compact Solid State Detector for Small Angle Particle Tracking

MIDAS (MIcrostrip Detector Array System) is a compact silicon tracking telescope for charged particles emitted at small angles in intermediate energy photonuclear reactions. It was realized to increase the angular acceptance of the DAPHNE detector and used in an experimental program to check the Gerasimov-Drell-Hearn sum rule at the Mainz electron microtron, MAMI. MIDAS provides a trigger for charged hadrons, p/pi identification and particle tracking in the region 7 deg < theta < 16 deg. In this paper we present the main characteristics of MIDAS and its measured performances.Comment: 13 pages (9 figures). Submitted to NIM

Coherent states for polynomial su(1,1) algebra and a conditionally solvable system

In a previous paper [{\it J. Phys. A: Math. Theor.} {\bf 40} (2007) 11105], we constructed a class of coherent states for a polynomially deformed $su(2)$ algebra. In this paper, we first prepare the discrete representations of the nonlinearly deformed $su(1,1)$ algebra. Then we extend the previous procedure to construct a discrete class of coherent states for a polynomial su(1,1) algebra which contains the Barut-Girardello set and the Perelomov set of the SU(1,1) coherent states as special cases. We also construct coherent states for the cubic algebra related to the conditionally solvable radial oscillator problem.Comment: 2 figure

Anisotropic dynamical scaling in a spin model with competing interactions

Results are presented for the kinetics of domain growth of a two-dimensional Ising spin model with competing interactions quenched from a disordered to a striped phase. The domain growth exponent are $\beta=1/2$ and $\beta=1/3$ for single-spin-flip and spin-exchange dynamics, as found in previous simulations. However the correlation functions measured in the direction parallel and transversal to the stripes are different as suggested by the existence of different interface energies between the ground states of the model. In the case of single-spin-flip dynamics an anisotropic version of the Ohta-Jasnow-Kawasaki theory for the pair scaling function can be used to fit our data.Comment: 4 pages, REVTeX fil

Equilibrium Properties of A Monomer-Monomer Catalytic Reaction on A One-Dimensional Chain

We study the equilibrium properties of a lattice-gas model of an $A + B \to 0$ catalytic reaction on a one-dimensional chain in contact with a reservoir for the particles. The particles of species $A$ and $B$ are in thermal contact with their vapor phases acting as reservoirs, i.e., they may adsorb onto empty lattice sites and may desorb from the lattice. If adsorbed $A$ and $B$ particles appear at neighboring lattice sites they instantaneously react and both desorb. For this model of a catalytic reaction in the adsorption-controlled limit, we derive analytically the expression of the pressure and present exact results for the mean densities of particles and for the compressibilities of the adsorbate as function of the chemical potentials of the two species.Comment: 19 pages, 5 figures, submitted to Phys. Rev.

Natalizumab affects T-cell phenotype in multiple sclerosis: implications for JCV reactivation

The anti-CD49d monoclonal antibody natalizumab is currently an effective therapy against the relapsing-remitting form of multiple sclerosis (RRMS). Natalizumab therapeutic efficacy is limited by the reactivation of the John Cunningham polyomavirus (JCV) and development of progressive multifocal leukoencephalopathy (PML). To correlate natalizumab-induced phenotypic modifications of peripheral blood T-lymphocytes with JCV reactivation, JCV-specific antibodies (serum), JCV-DNA (blood and urine), CD49d expression and relative abundance of peripheral blood T-lymphocyte subsets were longitudinally assessed in 26 natalizumab-treated RRMS patients. Statistical analyses were performed using GraphPad Prism and R. Natalizumab treatment reduced CD49d expression on memory and effector subsets of peripheral blood T-lymphocytes. Moreover, accumulation of peripheral blood CD8+ memory and effector cells was observed after 12 and 24 months of treatment. CD4+ and CD8+ T-lymphocyte immune-activation was increased after 24 months of treatment. Higher percentages of CD8+ effectors were observed in subjects with detectable JCV-DNA. Natalizumab reduces CD49d expression on CD8+ T-lymphocyte memory and effector subsets, limiting their migration to the central nervous system and determining their accumulation in peripheral blood. Impairment of central nervous system immune surveillance and reactivation of latent JCV, can explain the increased risk of PML development in natalizumab-treated RRMS subjects